• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Mary-Ellen Meadows, PhD


  • Chang G, Meadows ME, Smallwood JA, Antin JH, Orav EJ.Cognitive and Other Predictors of Change in Quality of Life One-Year After Treatment for Chronic Myelogenous Leukemia or Myelodysplastic Syndrome.J Neuropsychiatry Clin Neurosci. 2014 May 9.
  • Meadows ME, Chang G, Jones JA, Antin JR, Orav EJ.Predictors of Neuropsychological Change in Patients with Chronic Myelogenous Leukemia and Myelodysplastic Syndrome.Arch Clin Neuropsychol. 2013 Feb 7.
  • Chang G, Meadows ME, Jones JA, Antin JH, Orav EJ.Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS).Am J Drug Alcohol Abuse. 2010 Jan;36(1):1-6.
  • Chang G, Meadows ME, Orav EJ, Antin JH.Mental status changes after hematopoietic stem cell transplantation.Cancer. 2009 Oct 1;115(19):4625-35.